Pharnext was founded in April 2007 by Daniel Cohen and his collaborators – pioneers in modern genetics, genomics and pharmacogenomics.
Founders have high experience and achievements in science and entrepreneurship. Many of the founders of Pharnext work full time in the company.
Daniel Cohen, Chief Executive Officer
Serguei Nabirotchkin, Director of Nexus Dpt
Philippe Pouletty, SAB Member
Ilya Chumakov, Chief Scientific Officer
Loïc Heidsieck, Chief Financial Officer
Daniel Cohen, MD, PhD – Chairman of the Board & Chief Executive Officer
| Professor of Medical Genetics, founder of CEPH, Genethon and Millenium, former CSO at Genset and Global VP for Genetics at Serono. A founder of modern genetics, genomics and pharmacogenomics. Over 100 peer-reviewed papers (including 28 in high impact journals), more than 20 granted patents and many national and international awards and honors. |
Serguei Nabirotchkin, PhD, Director of Nexus Department
| A specialist in experimental genetics, cell signaling and systems biology. After graduating from Moscow University, he worked as a Lead Scientist at the Institute of Molecular Biology Institute in Moscow (Russia), DKFZ (Germany), the Institut Gustave Roussy Institute (France) and Genset (France). A former Director of the Animal Modl Department at the Serono Genetics Institute. |
Philippe Pouletty, MD – Board Member & Scientific Advisory Board Member
| Co-founder of Truffle Capital. Founder of three biotechnology companies (SangStat, Conjuchem and DrugAbuse Sciences). Honorary Chairman of France Biotech, (the leading French biotech industry association). Former Vice-Chairman of Europabio (the European biotech industry association), cited as an inventor on more than 20 granted patents. |
Ilya Chumakov, PhD, D-Sc – Board Member & Chief Scientific Officer
| PhD in Chemistry, D-Sc in Molecular Biology, very broad scientific culture and experience in genetics, genomics, molecular pharmacology and drug development, former director at CEPH, Genset and Serono Genetics Institute. Author of 87 peer- reviewed papers, including 14 in high-impact journals. Cited as an Inventor on 28 patents. |
Loic Heidsieck – Chief Financial Officer
| Senior manager with strong experience in multinational companies; High experience in financial management, organization of procedures, resource planning, project organization. 1976-1990: Auditor at Arthur Young, Financial Director at Autologic France and Franklin Mint France; 1991-1998: Serono, Administrative and Financial Director European operations. 1999-2002: Serono Geneva, Worldwide Corporate Controller; 2003-2006: General Manager of the Serono Genetics Institute (ex-Genset). |